M2K Bio is revolutionizing therapeutic antibody development through advanced artificial intelligence. By leveraging cutting-edge AI technology, the company analyzes complex genomics data to design next-generation antibody drugs. These innovative therapies are critical for treating a wide array of diseases, including cancers, autoimmune disorders, and infectious diseases.